Wouter A. van der Linden

2.9k citations
42 papers · 2.2k indexed · h-index 24
Topics
Ubiquitin and proteasome pathways (19 papers)Peptidase Inhibition and Analysis (12 papers)Protein Degradation and Inhibitors (8 papers)

In The Last Decade

Wouter A. van der Linden

42 papers receiving 2.2k citations

Peers

Wouter A. van der Linden
Comparison fields: 5 of 105
  • Molecular Biology 1.5k
  • Oncology 621
  • Organic Chemistry 436
  • Epidemiology 235
  • Cell Biology 234
Replace Kui Shen with:
Kui Shen United States
T. Krojer United Kingdom
Mary‐Ann Bjornsti United States
Miklós Békés United States
J.E. Debreczeni United Kingdom
Priscilla L. Yang United States
Christopher Tsu United States
Olivia W. Rossanese United States
Farid El Oualid Netherlands
Martijn Verdoes Netherlands
Wouter A. van der Linden relative to Kui Shen United States Kui Shen's profile →
Citations per field
00.5×3.5×
Kui Shen · 1×
Citations per year

Countries citing papers authored by Wouter A. van der Linden

Since Specialization
Citations

This map shows the geographic impact of Wouter A. van der Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter A. van der Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter A. van der Linden more than expected).

Fields of papers citing papers by Wouter A. van der Linden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter A. van der Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter A. van der Linden. The network helps show where Wouter A. van der Linden may publish in the future.

Co-authorship network of co-authors of Wouter A. van der Linden

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter A. van der Linden. A scholar is included among the top collaborators of Wouter A. van der Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter A. van der Linden. Wouter A. van der Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 22
3 36
4 171
5 157
6 8
7 69
8 41
9 65
10 11
11 42
12 70
13 438
14 29
15
Towards subunit specific proteasome inhibitors
1
16 55
17 70
18 48
19 11
20 163

About Wouter A. van der Linden

Wouter A. van der Linden is a scholar working on Oncology, Molecular Biology and Safety, Risk, Reliability and Quality, having authored 42 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (19 papers), Peptidase Inhibition and Analysis (12 papers) and Protein Degradation and Inhibitors (8 papers). The work is most often cited by research in Oncology (621 citations), Molecular Biology (1.5k citations) and Organic Chemistry (436 citations). Wouter A. van der Linden has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Herman S. Overkleeft, Alexei F. Kisselev, Matthew Bogyo, Martijn Verdoes, Bogdan I. Florea, Laura E. Sanman, Ehud Segal, Nimali P. Withana, Lianne I. Willems and Ian T. Foe. Their work appears in journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026